Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Second Secret of Life
Scientists have shed light on a key control process within cells that helps ensure our bodies function efficiently.

They have defined the shape of a protein molecule at different stages as it performs a key activity within a cell – breaking down sugar to turn it into energy.

The findings – which enable scientists to create graphics of the molecular structure at various stages of the process – could prove vital in informing the quest for new medicines.

Scientists hope that this initial development will lead them to gain insights into how the cells in our bodies function appropriately in response to changing needs.

Precisely how cells are regulated is a mystery, which has puzzled scientists for decades. The findings help to pinpoint how cells control their activities, for example how our heart is able to pump faster when we climb stairs, or how our digestive system breaks down a big meal.

The way proteins communicate within a cell is known as the 'second secret of life' – its importance in explaining the science of living things is ranked by scientists as second only to the discovery of DNA.

Scientists hope that this initial development will lead them to gain insights into how the cells in our bodies function appropriately in response to changing needs.
Scientists reached their findings by studying a protein from the parasite that causes sleeping sickness, which may aid the search for treatments for the disease.

The study, carried out in collaboration with the de Duve Institute, Brussels, is published in the Journal of Biological Chemistry and funded by the Medical Research Council, the Wellcome Trust, the Biotechnology and Biological Sciences Research Council and the European Commission.

Professor Malcolm Walkinshaw, of the University of Edinburgh's School of Biological Sciences, who took part in the research, said: "While this study looked at a protein linked to sleeping sickness, the basic principle applies to all cells, including those in our bodies. This helps us understand how our organs work to perform everyday tasks according to the needs of our bodies, such as how our liver cells process toxins, or lung cells enable us to breathe."

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.